Anticardiolipin antibodies are no marker for survived myocardial infarction
Tóm tắt
Antiphospholipid antibodies — both the lupus anticoagulant and anticardiolipin antibodies — are closely associated with arterial and venous thrombosis. In this prospective trial the IgM- and IgG-anticardiolipin antibodies in serum were determined in acute and chronic coronary artery disease. Seventy-four unselected males (34–87 years, mean 60) were included in the study. All patients underwent coronary angiography; infectious and autoimmune diseases were exclusion criteria. Sixteen patients had coronary artery disease (group A), 34 showed coronary stenoses with prior infarction (B), and 14 had survived an acute myocardial infarction (C), whereas 10 patients revealed no significant coronary narrowing (D; controls). The major risk factors were the same for all groups. Neither the IgM- nor the IgG-anticardiolipin antibody levels showed any significant difference in the four groups. The severity of coronary artery disease did not correlate to these antibodies. Furthermore, no correlation was found between elevated anticardiolipin antibodies and thrombocyte levels. Thus, a higher anticardiolipin level does not appear to be a marker for recurrent cardiovascular events.
Tài liệu tham khảo
Careras LO, Machin SJ, Deman R, Defreyn G, Vermylen J, Spitz B, Van Assche A (1981) Arterial thrombosis, intrauterine death and ‘lupus’ anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 8145:244–246
Cowchock S, Fort J, Munoz S, Norberg R, Maddrey W (1988) False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol 73:289–294
Eber B, Biondi ML, Auch-Schwelk W, Vanhoutte PM (1989) IgM-anticardiolipin antobidies evoke endothelium-independent relaxations in isolated canine coronary arteries. The Physiologist (abstract) 32:189
Feinstein DI (1985) Lupus anticoagulant, thrombosis, and fetal loss. N Engl J Med 313:1348–1350
Hamsten A, Norberg R, Björkholm M, DeFaire U, Holm G (1986) Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 8473:113–115
Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GRV (1984) Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 2:47–51
Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematodes. Lancet 8361:1211–1214
Hughes GRV, Harris NN, Gharavi AE (1986) The anticardiolipin syndrome. J Rheumatol 13:486–489
Kushner M, Simonian N (1989) Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia. Stroke 20:225–229
Moore JE, Mohr CF (1952) Biologically false positive serologic tests for syphilis. J Am Med Ass 150:467–473
Morton KE, Gavaghan TP, Krilis SA, Daggard GE, Baron DW, Hickie JB, Chesterman CN (1986) Coronary artery bypass graft failure — an autoimmune phenomenon? Lancet 8475:1353–1356
Lockshin MD, Druzin ML, Goei S, Quamar T, Magid MS, Jovanovic L, Ferenc M (1985) Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 313:152–156
Norberg R, Ernerudh J, Hamsten A, Unander AM, Arfors L (1987) Phospholipid antibodies in cardiovascular disease. Acta Med Scand 715:93–98
Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta M, Hughes GRV, Zanussi C, Balestrieri G (1988) Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematodes. Clin Exp Immunol 74:247–253
Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR (1988) Studies of IgG, IgM and IgA anti-phospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 15:74–79